FASLG and parasitic infectious disease: Similar treatment with anti-CD95L or anti-PD1 during infection of the highly susceptible A/Sn mice with parasites of the Y strain of T. cruzi did not reduce the parasitemia or the mortality, indicating that these treatments alone cannot substitute for immunization with AdASP-2 vaccine (AFA and MMR, unpublished results).